Five‐year quality of life results of the randomized clinical phase III (RADPLAT) trial, comparing concomitant intra‐arterial versus intravenous chemoradiotherapy in locally advanced head and neck cancer

The purpose of this investigation was to present 5‐years of quality‐of‐life (QOL) results of a multicenter randomized phase III trial, assessing intra‐arterial (IA) versus standard intravenous (IV) chemoradiation for inoperable stage IV head and neck cancer.

[1]  Irene Jacobi,et al.  Voice and speech outcomes of chemoradiation for advanced head and neck cancer: a systematic review , 2010, European Archives of Oto-Rhino-Laryngology.

[2]  F. Hoebers,et al.  Intra‐arterial versus intravenous chemoradiation for advanced head and neck cancer: Results of a randomized phase 3 trial , 2010, Cancer.

[3]  F. Hilgers,et al.  The surgical dilemma of ‘functional inoperability’ in oral and oropharyngeal cancer: current consensus on operability with regard to functional results , 2009, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[4]  F. Hilgers,et al.  First‐year quality of life assessment of an intra‐arterial (RADPLAT) versus intravenous chemoradiation phase III trial , 2009, Head & neck.

[5]  C. Lazarus,et al.  Swallowing disorders in the first year after radiation and chemoradiation , 2008, Head & neck.

[6]  D. Goldstein,et al.  Health‐related quality of life profiles based on survivorship status for head and neck cancer patients , 2007, Head & neck.

[7]  R. Morton,et al.  Deterioration in quality‐of‐life of late (10‐year) survivors of head and neck cancer , 2006, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[8]  Merete Osler,et al.  Effect of smoking reduction on lung cancer risk. , 2005, JAMA.

[9]  G. Lockwood,et al.  Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia. , 2005, International journal of radiation oncology, biology, physics.

[10]  F. Hilgers,et al.  Quality of life assessment in laryngectomized individuals: do we need additions to standard questionnaires in specific clinical research projects? , 2005, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[11]  I. Tan,et al.  High‐dose superselective intra‐arterial cisplatin and concomitant radiation (radplat) for advanced head and neck cancer , 2004, Head & neck.

[12]  M. List,et al.  Functional outcomes in head and neck cancer. , 2004, Seminars in radiation oncology.

[13]  R. Morton,et al.  Studies in the Quality of Life of Head and Neck Cancer Patients: Results of a Two‐Year Longitudinal Study and a Comparative Cross‐Sectional Cross‐Cultural Survey , 2003, The Laryngoscope.

[14]  C. Kermer,et al.  Quality of life 2-10 years after combined treatment for advanced oral and oropharyngeal cancer. , 2002, International journal of oral and maxillofacial surgery.

[15]  J. Schornagel,et al.  Quality-of-life assessment after supradose selective intra-arterial cisplatin and concomitant radiation (RADPLAT) for inoperable stage IV head and neck squamous cell carcinoma. , 2002, Archives of otolaryngology--head & neck surgery.

[16]  J. Pignon,et al.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta analysis of chemotherapy on head and neck cancer , 2001 .

[17]  M. Sullivan,et al.  Health‐related quality of life three years after diagnosis of head and neck cancer—A longitudinal study , 2001, Head & neck.

[18]  J. Bourhis,et al.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data , 2000, The Lancet.

[19]  K. Robbins.  The evolving role of combined modality therapy in head and neck cancer. , 2000, Archives of otolaryngology--head & neck surgery.

[20]  G. Hordijk,et al.  Long‐Term Quality of Life of Patients With Head and Neck Cancer , 2000, The Laryngoscope.

[21]  P. Fayers,et al.  Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  F. Hilgers,et al.  Structured assessment of the consequences of composite resection. , 1998, Clinical otolaryngology and allied sciences.

[23]  F. Hilgers,et al.  Psychologic aspects of major head and neck reconstructive surgery. , 1995, Facial plastic surgery : FPS.

[24]  S. Howell,et al.  A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer. , 1994, American journal of surgery.

[25]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.